Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001136261-08-000084
Filing Date
2008-05-19
Accepted
2008-05-19 16:34:16
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10ka.htm 10-K/A 1563457
3 RATIO OF EARNINGS exh12-1.htm EX-12.1 23759
4 CONSENT exh23-1.htm EX-23.1 3187
5 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 6397
6 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 6406
7 906 CERTIFICATE exh32.htm EX-32 2884
8 10-K/A form10-ka.pdf 10-K/A 846268
9 RATIO OF EARNINGS exhibit12-1.pdf EX-12.1 7955
10 CONSENT exhibit23-1.pdf EX-23.1 19390
11 CEO 302 CERTIFICATE exhibit31-1.pdf EX-31.1 34564
12 CFO 302 CERTIFICATE exhibit31-2.pdf EX-31.2 34653
13 906 CERTIFICATE exhibit32.pdf EX-32 25280
14 LOGO logo.jpg GRAPHIC 8509
  Complete submission text file 0001136261-08-000084.txt   2954177
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23272 | Film No.: 08845657
SIC: 2836 Biological Products, (No Diagnostic Substances)